Last reviewed · How we verify
Triferic
At a glance
| Generic name | Triferic |
|---|---|
| Also known as | ferric pyrophosphate citrate (FPC), ferric pyrophosphate citrate, FPC |
| Sponsor | Rockwell Medical Technologies, Inc. |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | discontinued |
Approved indications
- Iron supplement therapy
Common side effects
Key clinical trials
- Anemia Treatment in Inflammatory Bowel Disease: Predictive Factors of Response to Oral Iron Treatment (Phase 4)
- NCT01135576 (NA)
- Triferic AVNU Infusion Via Freedom Pump During Hemodialysis (Phase 4)
- Pharmacokinetics of Triferic (Ferric Pyrophosphate Citrate) Administered Via Dialysate and IV to Pediatric Patients on Chronic Hemodialysis (Phase 1)
- Comparison of Iron Absorption From Extruded FePP-fortified Rice Containing Different Zinc Compounds, Citric Acid/Trisodium Citrate and Sodium EDTA (NA)
- Relative Bioavailability of Iron and Folic Acid From a New Powdered Supplement Compared to a Traditional Tablet in Pregnant Women (Phase 1)
- Comparative Evaluations of Micronutrient Absorption From Mineral Fortified Rice Produced With Different Fortification Techniques: An Evaluation of Hot and Cold Extrusion (Study 1) and Coating Technolo (NA)
- Pharmacokinetics and Preliminary Bioequivalence of Triferic (Ferric Pyrophosphate Citrate) Administered Via Hemodialysate and Intravenously to Adult CKD-5HD Patients (Phase 1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Triferic CI brief — competitive landscape report
- Triferic updates RSS · CI watch RSS
- Rockwell Medical Technologies, Inc. portfolio CI